Mutation of Tyrosine 960 within the Insulin Receptor Juxtamembrane Domain Impairs Glucose Transport but Does Not Inhibit Ligand-mediated Phosphorylation of Insulin Receptor Substrate-2 in 3T3-L1 Adipocytes-Reference-Cited by-同舟云学术

Mutation of Tyrosine 960 within the Insulin Receptor Juxtamembrane Domain Impairs Glucose Transport but Does Not Inhibit Ligand-mediated Phosphorylation of Insulin Receptor Substrate-2 in 3T3-L1 Adipocytes

Published:1999-04 Issue:17 Volume:274 Page:12075-12080
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Chaika Oleg V.,Chaika Nina,Volle Deanna J.,Hayashi Hideki,Ebina Yousuke,Wang Ling-Mei,Pierce Jacalyn H.,Lewis Robert E.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference45 articles.

1. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity

2. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.

3. Augmented Mitogenesis and Impaired Metabolic Signaling Mediated by a Truncated Insulin Receptor

4. Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors.

5. Identification of insulin receptor tyrosine residues autophosphorylated in vitro.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive insulin receptor phosphorylation dynamics profiled by mass spectrometry;The FEBS Journal;2021-12-13

2. Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training;Comprehensive Physiology;2013-01

3. KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin Sensitivity;Cell Metabolism;2009-11

4. Chapter 3 Molecular Mechanisms of Differential Intracellular Signaling From the Insulin Receptor;Vitamins & Hormones;2009

5. Insulin Resistance and Inhibitors of the Insulin Receptor Tyrosine Kinase;The Metabolic Syndrome;2008